The post is raw, but the question is direct: why is the United States falling behind in the open LLM market? The user cites DeepSeek, Kimi, GLM and MiniMax as examples of a Chinese list they call endless. Then the detail that turns the vent into a snapshot: when asked 'why can't we have American AI as good as or better than the Chinese?', the most-upvoted comment answers 'Have you even thought of shareholder value!?'.

It is a quip, but it captures a mechanism. When capital drives the technical agenda, resources flow to projects that maximize immediate returns: closed API services, high-margin enterprise contracts, hardware bundled with proprietary platforms. Open source and open weights, which do not produce an easy per-token fee, become a cost to justify. As a result, the center of gravity for open innovation shifts toward actors with less quarterly investor pressure and more strategic interest in building exportable alternatives.

For teams managing local infrastructure, the difference is not academic. An open model ecosystem changes the cost of exiting the cloud: if a team can download or adapt a self-hosted model, dependence on a single endpoint decreases. This is not a matter of absolute performance, but of incentive architecture. Closed models sell access; open models make deployment possible. In a market where data sovereignty and latency matter, the second approach shifts power toward whoever manages the data. From a TCO perspective, an open model can lower variable inference costs, but it shifts the burden of management, updates and security onto the team. For those evaluating on-premise deployment, the trade-offs between open models and closed API services are covered in AI-RADAR's analytical frameworks at /llm-onpremise.

The paradox is that chasing shareholder value risks losing control of the platform on which that value is built. If the most widely adopted open models come from outside, American vendors will have to integrate them or compete on terrain defined by others. This is not a forecast, but a tension already visible in how companies talk about open LLMs: less as a research lab and more as a competitive variable.

The source reports no benchmarks or adoption data. It is a thermometer of frustration circulating among practitioners. But thermometers sometimes read before balance sheets do. The question, in the end, is not whether the United States can catch up. It is whether the American market can tolerate innovation that does not immediately translate into shareholder value. The post offers no answer. It offers the symptom.